Glutathione and protein thiol groups (GSH/PSH)

Glutathione and protein thiol groups represent the primary cellular defense mechanism against oxidative stress and electrophilic insults (PubChem CID 124886). Glutathione, a tripeptide consisting of glutamate, cysteine, and glycine, acts as a potent antioxidant and a substrate for detoxification enzymes like glutathione S-transferases (NIH/NCBI). Protein thiol groups, specifically the sulfhydryl side chains of cysteine residues, are critical for maintaining protein structure through disulfide bond formation and for regulating enzyme activity via redox-sensitive switches (Nature Reviews Molecular Cell Biology). In many pathological states, such as cancer, elevated glutathione levels contribute to drug resistance by neutralizing chemotherapeutic agents before they reach their intended targets (PubMed, PMID: 25613708). Conversely, the depletion of these thiol pools, as seen in acetaminophen overdose, leads to catastrophic cellular damage and organ failure (StatPearls, Acetaminophen Toxicity). Pharmacological strategies often involve either replenishing these pools using precursors like N-acetylcysteine or intentionally depleting them with agents like buthionine sulfoximine to sensitize diseased cells to treatment (StatPearls, N-Acetylcysteine). Additionally, many modern covalent drugs are designed to interact specifically with certain protein thiols, while avoiding the general glutathione pool to minimize off-target effects. Monitoring the redox state of these thiols serves as a critical indicator of cellular health and therapeutic efficacy in various clinical settings.

Other names

Reduced glutathioneSulfhydryl groupsProtein sulfhydrylsGSHThiolsL-gamma-glutamyl-L-cysteinyl-glycine

Drugs interact with these groups primarily through covalent conjugation (e.g., NAPQI binding to thiols) or by modulating their synthesis and redox state to either deplete antioxidant capacity or restore it (StatPearls, Acetaminophen Toxicity; PubMed, PMID: 25613708).